Gender Differences in Metabolic Syndrome – A Key Research Issue

Author(s): Abishek Iyer, Kathleen Kauter, Lindsay Brown

Journal Name: Endocrine, Metabolic & Immune Disorders - Drug Targets
Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 11 , Issue 3 , 2011

Become EABM
Become Reviewer
Call for Editor


Metabolic syndrome as a clustering of risk factors for diabetes and cardiovascular disease affects both men and women, but with important gender differences. Animal models have been used to understand disease progression and define therapeutic options, but most pre-clinical research on metabolic syndrome is undertaken in males. This opinion piece discusses the differences in male and female physiology that may influence both the development and the responses to pharmacological interventions of metabolic disorders, especially obesity. An appreciation of gender differences should improve the design and usefulness of biomedical experimental research to allow the development of relevant genderbased treatment options for chronic diseases including obesity, metabolic and cardiovascular diseases.

Keywords: Female bias, metabolic syndrome, inflammation, cardiovascular disease, reproduction, rat reproductive biology, socioeconomic, uterine, breast cancers, rheumatoid arthritis, multiple sclerosis, systemic lupus, autism, schizophrenia, asthma

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [182 - 188]
Pages: 7
DOI: 10.2174/187153011796429808
Price: $65

Article Metrics

PDF: 9